The Life & Science Podcast podcast

Science NOT Sides | Cátia Moutinho | S1 E4

0:00
1:27:03
Spol 15 sekunder tilbage
Spol 15 sekunder frem

In this episode of The Life & Science Podcast, we talk with Cátia Moutinho about why there is no best single cell or spatial technology, and why so few people will tell you that.

Cátia studied biology in the Azores, then followed cancer research from Porto to Madrid and Barcelona, spending around nine years in one lab. She helped build a single cell wet lab when everything was still manual, led a team in Sydney, and after returning to Portugal founded The Single Cell World. Next: leading a lab again.

We discuss:

  • Learning single cell by failing, and starting a blog to stop other people failing the same way
  • Why benchmarking is so hard: same instrument, same samples, different lab, different result
  • “Which one is best?” and why her answer is always “what is your sample?”
  • How she handles work for companies, pharma and researchers
  • Why she thinks AI can find patterns but can’t tell you if the tissue was placed well on the slide
  • The gap in access: researchers in Egypt who know the technology but can’t afford it, and what she’d like companies to do

If you are a young researcher, someone choosing between single cell and spatial platforms, a scientist weighing life beyond the bench, or anyone who has watched an expensive experiment fail, you'll recognise yourself in this conversation.

Chapters

0:00 Meet Cátia Moutinho
1:31 From the Azores to Madrid and Barcelona
3:55 From manual single cell work to Sydney
6:17 "I learn by failing": The Single Cell World
10:01 Leaving the bench, not academia
10:37 How histology prepared her for spatial
11:49 Riding the single cell train
13:22 "There is no best technology"
16:03 Why one blog post takes days
17:44 Benchmarking and reproducibility in the real world
22:07 Why kits are tested on easy samples
23:49 Which platform is the best?
30:03 Litigation between companies and its cost to researchers
37:55 Failure and mentors in academia
39:49 Leading a team with vulnerability
43:03 Moving from the bench to freelancing
44:12 "Never say never" and the stress of freelancing
47:40 Why she keeps writing
49:46 Where single cell and spatial go next
52:00 What AI cannot see in spatial data
55:58 The case for epigenetics
57:58 Dreams of leading a lab again
1:01:59 Clinical translation and rare cancers
1:04:30 Why pharma adopts slowly
1:09:57 A plea to companies on access
1:12:55 Advice for young scientists: network and travel
1:21:01 Dutch courage: was leaving the bench worth it?
1:23:09 What worries her, and what she is proud of
1:25:08 Final message: smile at a stranger
1:26:48 After the record news from Cátia

 Should single cell and spatial companies fund independent benchmarking and wider access, or is it up to researchers to find the limits themselves?

Tell us in the comments, and follow The Life & Science Podcast for the next episode.

#SingleCell #SpatialTranscriptomics #Epigenetics #CareerInScience #ScientificIndependence #SRC-Search

src-search.com

Flere episoder fra "The Life & Science Podcast"